AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020
Jun 10, 2020
30583_dirs_2020-06-09_fb25b8d5-3c84-42c0-a8d1-f6ad5f295c8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-06-05
Reporting Person: LAWLIS V BRYAN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-05 | Common Stock | S | 4430 | $107.46 | Disposed | 18850 | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on January 16, 2020.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19